Clinical Trial Update: Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating aripiprazole oral solution for children and adolescents with autistic disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder

Drugs mentioned

• aripiprazole oral solution (aripiprazole)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Autistic Disorder | Phase 3 | Status: COMPLETED